Increasing cases of osteoporosis, which can accelerate tissue aging, is another factor that may positively impact the market. However, stringent regulations imposed by federal agencies regarding the approval of supplements may have a deterrent effect on growth. Increasing clinical research activities related to vitamin K2 product development in developed countries will positively stimulate industry growth during the forecast period. Researchers and scientists are focusing on the role of vitamins in babies and adults. Few institutions in this region are studying the bioavailability and intestinal absorption of menadione and phytonadione to help healthcare professionals understand metabolic processes. Scientists have also developed drugs to help treat babies with bleeding disorders. As a result, the increase in research activities will boost the demand for Vit-K which will exceed commercial revenues in the future.